O

Orchard Healthcare Research Inc. | Skokie, IL

Research site
(Unclaimed)
Location
9711 Skokie Boulevard Suite B, Skokie, Illinois, United States of America
Site insights

Top conditions

Lung Cancer (4 trials)

Non-Small-Cell Lung Carcinoma (4 trials)

Breast Cancer (3 trials)

Syndrome (3 trials)

Preleukemia (3 trials)

Top treatments

Lenalidomide
Docetaxel
Dexamethasone
Gemcitabine
Telaglenastat
Glembatumumab
ICP-022
Orelabrutinib
Sitravatinib
Tamibarotene

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 19
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies

This is a Phase I/II, multicenter, open-label study to evaluate the safety, efficacy, tolerability, and pharmacokinetics of a novel BTK inhibitor, Or...

Active, not recruiting
Part 2:B-cell Malignancies
Part 1:r/r B-cell Malignancies
Drug: Orelabrutinib (ICP-022)

The purpose of this study is to learn about the safety and how effective the study medicine (PF-07220060) plus fulvestrant is compared to the study d...

Enrolling
Advanced or Metastatic Breast Cancer
Drug: Fulvestrant
Drug: Exemestane

The purpose of the study is to compare the efficacy and safety of Luspatercept vs epoetin alfa in the treatment of anemia in adults due to IPSS-R ver...

Enrolling
Myelodysplastic Syndromes
Biological: Epoetin Alfa
Biological: Luspatercept

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-cell NHL. Lenalidomide is a...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

This study will compare the efficacy of the investigational agent sitravatinib in combination with nivolumab versus docetaxel in patients with advanc...

Active, not recruiting
Metastatic Non-Squamous Non-Small Cell Lung Cancer
Drug: Sitravatinib
Drug: Docetaxel

The goal of this clinical study is to learn more about the study drug, sacituzumab govitecan-hziy (SG), and its dosing in combination with pembrolizu...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Sacituzumab Govitecan-hziy (SG)
Drug: Pembrolizumab

This study compares the efficacy of Tamibarotene in combination with azacitidine to azacitidine in combination with placebo in participants who are R...

Enrolling
Myelodysplastic Syndromes
Drug: Azacitidine
Drug: Tamibarotene

Trial sponsors

Bristol-Myers Squibb (BMS) logo

Bristol-Myers Squibb (BMS) (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems